Literature DB >> 16322233

Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive front.

Kumari L Andarawewa1, Elena R Motrescu, Marie-Pierre Chenard, Anne Gansmuller, Isabelle Stoll, Catherine Tomasetto, Marie-Christine Rio.   

Abstract

The initial invasive processes during cancer development remain largely unknown. Stromelysin-3/matrix metalloproteinase 11 (ST3/MMP11) is associated with tumor invasion and poor prognosis. We present novel evidence that adipocytes present at human breast tumor invasive front are induced by cancer cells to express ST3. Using mouse syngeneic model, light and electron microscopy showed that in ST3-deficient mice but not in wild-type mice, forced cancer cell-adipocyte interaction/crosstalk results in adipocyte membrane alteration, allowing cancer cell fat infiltration and death. Thus, adipocytes are involved in initial cancer cell survival into connective tissue, and this effect is ST3 mediated. This suggested that ST3 might play a role in adipocyte metabolism. Accordingly, ST3-deficient mice exhibited fat excess and increased mRNA levels of peroxisome proliferator-activated receptor gamma (PPARgamma) and adipocyte protein 2 (aP2) adipogenic markers, indicating that, in vivo, ST3 negatively regulates fat homeostasis. Moreover, ST3-deficient mouse embryonic fibroblasts exhibited a dramatic enhanced potential to differentiate into adipocytes associated with increased PPARgamma and aP2 expression, and recombinant ST3 treatment reverted their differentiation. Thus, in vitro, ST3 reduces adipocyte differentiation in an autocrine manner. High fibroblasts/adipocytes ratio is a stroma feature, and peritumoral fibroblast origin remains debated. Our results support the concept that invading cancer cells aberrantly restore the negative ST3 function on adipogenesis into proximal adipocytes/preadipocytes, leading to the accumulation/maintenance of a particular peritumoral fibroblast subpopulation. Accordingly, in human breast tumors, we observed that ST3-expressing peritumoral fibroblasts are distinct from alpha-smooth muscle actin-expressing myofibroblasts. This constitutes the first report of implication of a MMP in cancer cell-adipocyte interaction/crosstalk during early steps of connective tissue invasion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16322233     DOI: 10.1158/0008-5472.CAN-05-1231

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  62 in total

1.  Interleukin-8 Activates Breast Cancer-Associated Adipocytes and Promotes Their Angiogenesis- and Tumorigenesis-Promoting Effects.

Authors:  Huda H Al-Khalaf; Bothaina Al-Harbi; Adher Al-Sayed; Maria Arafah; Asma Tulbah; Abdulaziz Jarman; Falah Al-Mohanna; Abdelilah Aboussekhra
Journal:  Mol Cell Biol       Date:  2019-01-03       Impact factor: 4.272

2.  Inflamed tumor-associated adipose tissue is a depot for macrophages that stimulate tumor growth and angiogenesis.

Authors:  Marek Wagner; Rolf Bjerkvig; Helge Wiig; Juan M Melero-Martin; Ruei-Zeng Lin; Michael Klagsbrun; Andrew C Dudley
Journal:  Angiogenesis       Date:  2012-05-22       Impact factor: 9.596

Review 3.  Hematopoietic stem cell-derived adipocytes and fibroblasts in the tumor microenvironment.

Authors:  Ying Xiong; Lindsay T McDonald; Dayvia L Russell; Ryan R Kelly; Katie R Wilson; Meenal Mehrotra; Adam C Soloff; Amanda C LaRue
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

Review 4.  Adipocytes: impact on tumor growth and potential sites for therapeutic intervention.

Authors:  Simona Hefetz-Sela; Philipp E Scherer
Journal:  Pharmacol Ther       Date:  2013-01-24       Impact factor: 12.310

5.  Gene expression differences in adipose tissue associated with breast tumorigenesis.

Authors:  Lori A Sturtz; Brenda Deyarmin; Ryan van Laar; William Yarina; Craig D Shriver; Rachel E Ellsworth
Journal:  Adipocyte       Date:  2014-02-20       Impact factor: 4.534

Review 6.  The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases.

Authors:  Griselda A Cabral-Pacheco; Idalia Garza-Veloz; Claudia Castruita-De la Rosa; Jesús M Ramirez-Acuña; Braulio A Perez-Romero; Jesús F Guerrero-Rodriguez; Nadia Martinez-Avila; Margarita L Martinez-Fierro
Journal:  Int J Mol Sci       Date:  2020-12-20       Impact factor: 5.923

Review 7.  Proteases in cutaneous malignant melanoma: relevance as biomarker and therapeutic target.

Authors:  Eleonore Fröhlich
Journal:  Cell Mol Life Sci       Date:  2010-08-05       Impact factor: 9.261

Review 8.  Studying Adipose Tissue in the Breast Tumor Microenvironment In Vitro: Progress and Opportunities.

Authors:  David Mertz; Jason Sentosa; Gary Luker; Shuichi Takayama
Journal:  Tissue Eng Regen Med       Date:  2020-09-16       Impact factor: 4.169

Review 9.  Obesity and cancer--mechanisms underlying tumour progression and recurrence.

Authors:  Jiyoung Park; Thomas S Morley; Min Kim; Deborah J Clegg; Philipp E Scherer
Journal:  Nat Rev Endocrinol       Date:  2014-06-17       Impact factor: 43.330

Review 10.  Adipocyte extracellular matrix composition, dynamics and role in obesity.

Authors:  Edwin C M Mariman; Ping Wang
Journal:  Cell Mol Life Sci       Date:  2010-01-27       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.